The largest database of trusted experimental protocols
Sourced in United States

C. tropicalis is a fungal strain maintained by the American Type Culture Collection. It is a unicellular yeast that can be used for various laboratory applications.

Automatically generated - may contain errors

16 protocols using c tropicalis

1

Evaluation of Perylene Bisimide Derivatives Against Fungal Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two perylene bisimide derivatives were evaluated with 47 fungal strains. Nine yeast strains of reference (Candida glabrata ATCC 90030, C. tropicalis ATCC 750, C. tropicalis ATCC 200956, C. albicans SC5314, C. krusei ATCC 6258, C. lusitaniae ATCC 2819, C. albicans ATCC 64548, Cryptococcus gattii CBS 10865, and C. neoformans var grubii ATCC 208821) were included. Furthermore, 37 filamentous fungi were distributed between the clinical isolations of Fusarium spp. (17), Neoscytalidium spp. (6), and Scedosporium spp. (1) from patients with onychomycoses. Ten clinical isolates of Sporothrix spp. from patients with sporothrichosis were evaluated. The following reference strains of filamentous fungi were included: Fusarium oxysporum ATCC 48112, Aspergillus flavus ATCC 204304, and Aspergillus fumigatus ATCC 204305 and Trichophyton mentagrophytes (T. interdigitale) ATCC 24198.
+ Open protocol
+ Expand
2

Antifungal Activity of Vitex agnus-castus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eleven Candida strains were used to assess the antifungal activity of Vitex agnus-castus. The species were four strains purchased from (ATCC, Manassas, VA, United States) included C. albicans (ATCC® 60,193™), C. krusei (ATCC® 14,243™) (Ck1), C. parapsilosis (ATCC® 22,019™) (Cp1), C. tropicalis (ATCC® 66,029™). Other seven strains were obtained from either King Khalid University Hospital (KKUH), or King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia, and included C. parapsilosis (Cp2), Candida famata, C. rhodotorula, C. dublinesis, C. auris, C. krusei (Ck2), and C. krusei (Ck3). The fresh inoculum was prepared by subculturing the studied species onto a Sabouraud dextrose agar (SDA) medium at 28 °C for 48 h, as previously described [23 (link)]. The turbidity of growing Candida suspension was adjusted to match the turbidity standard of 0.5 McFarland units, by spectrophotometry tune of 0.1 OD and was read at 600 nm wavelength.
+ Open protocol
+ Expand
3

Antimicrobial Activity Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh overnight cultures of various aerobically grown reference strains of bacteria and yeasts from the American Type Culture Collection (ATCC) were used in all experiments. The panel of the tested microorganisms included Gram-positive bacteria: Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis ATCC 12228, Micrococcus luteus ATCC 10240, and Bacillus subtilis ATCC 6633 and Gram-negative bacteria: Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Klebsiella pneumoniae ATCC 13883. For the determination of antifungal activity, various reference strains of Candida spp. were used: C. albicans ATCC 10231, C. glabrata ATCC 15126, C. glabrata ATCC 90030, C. krusei ATCC 14243, C. auris CDC B11903, C. lusitaniae ATCC 3449, and C. tropicalis ATCC 1369.
+ Open protocol
+ Expand
4

Comparative Evaluation of Candida Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following standard strains were used: C. albicans (ATCC 90028), C. dubliniensis (ATCC MYA-646), C. guilliermondii (ATCC 6260), C. glabrata (ATCC 2001), C. krusei (ATCC 6258), C. metapsilosis (ATCC 96143), C. orthopsilosis (ATCC 96141), C. parapsilosis (ATCC 22019) and C. tropicalis (ATCC 13803), obtained from American Type Culture Collection (ATCC). In addition, a clinical isolate of C. auris was used, kindly provided by Hospital das Clinicas, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo (HCFMRP/USP), isolated from the blood of a patient. All yeasts used in this study are part of the culture collection of the Laboratory of Antimicrobial Testing of the Federal University of Uberlândia (LEA/UFU), preserved in deep freezing at − 80 °C until the start of tests.
+ Open protocol
+ Expand
5

Profiling Candida and Geotrichum Species

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight strains of yeast were obtained from the American Type Culture Collection (ATCC): C. albicans ATCC 10231, C. glabrata ATCC 15126, C. parapsilosis ATCC 22099, C. tropicalis ATCC 13803, C. krusei ATCC 14243, Candida kefyr ATCC 204093, C. auris ATCC MYA-5001, and G. capitatum ATCC 201230. The clinical isolates of C. albicans (CA1-CA20) were obtained as stock cultures from the Jan Boży Independent Public Provincial Hospital in Lublin, Poland. The strains were identified using VITEK 2 YST IC CARDS (Biomerieux). Stock cultures were stored at −70°C, subcultured on YPDA medium (1% yeast extract, 2% peptone, 2% dextrose, and 2% agar), and stored at 4°C. The fungal strain cultures were routinely maintained in YPD medium (1% yeast extract, 2% peptone, 2% dextrose) at 30°C.
+ Open protocol
+ Expand
6

Antimicrobial Activity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Different microorganisms including Gram-negative bacteria; Escherichia coli (RCMB 010056), Klebsiella pneumonia (RCMB 0010093), Proteous vulgaris (RCMB 010085), Pseudomonas aeruginosa (RCMB 0100243-5), and Salmonella typhimurium(RCMB 006 (1) ATCC 14028), Gram-positive bacteria; Bacillus subtilis(RCMB 015 (1) NRRL B-543), Staphylococcus epidermidis (RCMB 010027), Streptococcus mutans (RCMB 0100172), Streptococcus pneumoniae (RCMB 0100170-3), Stroptococcus pyogenes (RCMB 0100174-2) and; and fungal strains; Aspergillus fumigatus (RCMB 02568), Candida albicans (RCMB 05036), C. tropicalis (RCMB 05239), Geotricum candidum (RCMB 05097), and Syncephalastrum racemosum (RCMB 09041) were obtained from the Microbiology Laboratory, Regional Center for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt and used as test organisms.
+ Open protocol
+ Expand
7

Microbiological Assays of Antimicrobial Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals (reagents, standards, ELISA kit, and culture media) were procured from Sigma-Aldrich (St. Louis, MO, USA), R&D Systems (Minneapolis, MN, USA), and Promega Corporation (Madison, WI, USA). The following standard bacterial and yeast strains were used in the microbiological assays: Methicillin-resistant Staphylococcus aureus (MRSA, ATCC 33591), Staphylococcus aureus (ATCC 25923), Klebsiella pneumoniae (ATCC 27736), Escherichia coli EHEC (ATCC 43895), Pseudomonas aeruginosa (ATCC 27853), Candida albicans (MYA 2876), C. glabrata (ATCC 90030), C. tropicalis (ATCC 750), C. parapsilosis (ATCC 2019), Streptococcus salivarius (ATCC 7073), and S. sanguinis (SK36). The strains were grown in Sabouraud Dextrose agar (SDA, Kasvi), Brain Heart Infusion (BHI), or RPMI culture media.
+ Open protocol
+ Expand
8

Microbial Collection and Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microorganisms Acinterbacter baumannii (ATCC 19606), Pseudomonas aeruginosa (ATCC 25668), Klebsiella pneumonia (ATCC 15380), Escherichia coli, Enterococcus faecalis (ATCC 29212), Staphylococcus aureus, Salmonella typhimurium, Streptococcus pyogenes, Candida albicans (ATCC 2091), C. tropicalis (ATCC 20336) were obtained from The University of Hertfordshire microorganism collection. Bacterial and fungal stock cultures were grown on nutrient and yeast peptone dextrose agar plates, respectively, and then grown and diluted with corresponding broths for desired dilutions.
+ Open protocol
+ Expand
9

In Vitro Antifungal Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds 14 and 15 were evaluated for antifungal activity in vitro using commercial antifungals such as fluconazole for yeasts and itraconazole for fungi. Activities are reported in the minimum inhibitory concentration (MIC) values using the serial microdilution method on 96-well plates. The following reference strains were purchased from the American Type Culture Collection (ATCC): Candida albicans ATCC 24433, C. glabrata ATCC 66032, C. guilliermondii ATCC 6260, C. krusei ATCC 14243, C. tropicalis ATCC 750, A. niger ATCC 16404 and A. fumigatus ATCC 204305. The MIC values were determined according to the M27-S4 method of the Clinical Laboratory Standards Institute for yeasts [34 ] and the M38 method for fungi [35 ]. The RPMI-1740 (Sigma) culture medium buffered with 0.165 M of HEPES (Sigma) was used. The MIC values were defined as the minimum concentration that inhibits growth of ≥ 50% Candida spp. and % Aspergillus spp. in comparison to the controls. The compounds were dissolved in ethanol and serially diluted in the growth medium. The yeasts were incubated to 35–37 °C and the MIC values were measured at 24 and 48 h; the fungi were incubated to 35–37 °C and measured at 48 and 72 h.
+ Open protocol
+ Expand
10

Antifungal Susceptibility of Candida Species

Check if the same lab product or an alternative is used in the 5 most similar protocols
The microorganisms used in this study were Candida albicans ATCC 9002, C. parapsilosis ATCC 22019, C. tropicalis ATCC 750, C. krusei ATCC 6258, C. lusitaniae ATCC 200950, (American Type Culture Collection), Cryptococcus neoformans IP95026 (Institut Pasteur France) and two clinical isolates namely C. guilliermondii and C. glabrata (Centre Pasteur Yaounde-Cameroon). Sabouraud dextrose agar (SDA) (Liofilchem Laboratories) was used for the maintenance and culture of fungal strains while Sabouraud dextrose broth (SDB) was used for the determination of the minimum inhibitory concentrations (MICs) and the minimum fungicidal concentrations (MFCs).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!